Top 10 Medical Device Startup Investors in Portugal in October 2023
Top 10 Medical Device Startup Investors in Portugal in October 2023
| Investor | Medical Device Portugal investments |
|---|---|
| Portugal Ventures | 6 |
| Caixa Capital | 3 |
| Armilar Venture Partners | 2 |
| Bynd Venture Capital | 2 |
| Social Impact Fund | 1 |
| MSM | 1 |
| Artesian VC | 1 |
| Beta Capital | 1 |
| Boule Diagnostics | 1 |
| EIT Health | 1 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Portugal Ventures is a venture capital firm that is part of the Banco Português de Fomento group, currently manages 170 million euros and has more than 130 portfolio companies. It invests in startups in the pre-seed, seed and series A stages that offer innovative solutions for the international market in the digital, engineering&industry, lifesciences, and tourism sectors. Since 2012, Portugal ventures has invested 164 million euros in 147 new businesses.
Show more...Investment focus
- Software, Health Care, Information Technology
- Seed, Funding Round, Pre-Seed
- Portugal, United States, France
Portfolio highlights
- HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
- MyCareforce — The platform that connects nurses to available shifts.
- Floating Particle — Floating Particle is a technology and innovation company that drives an innovative solution for waste management and clean energy. Floating Particle specializes in IoT, Big Data and Machine Learning to provide cutting-edge technology to the customers.
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Portugal, United States, Spain
Portfolio highlights
- HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
- Probely — Probely is a web application and API vulnerability scanner for agile teams. Automate Security Testing by adding Probely into your SDLC and CI/CD pipelines.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more...Investment focus
- Software, Information Technology, Manufacturing
- Series A, Seed, Funding Round
- Portugal, United States, United Kingdom
Portfolio highlights
- Appentra — The first static code analyzer that increases the performance of C/C++ code. Write hardware-friendly code that runs faster on modern hardware.
- StudentFinance — Catapult your career with leading re-skilling and up-skilling bootcamps. Study now and pay us back once you land a job & start earning!
- Miles in the Sky — Embark on a journey with Miles to upgrade your learning experiences. Our unique model provides a better way to increase learner engagement and improve knowledge retention.
Bynd Venture Capital, former Busy Angels, is a Portuguese venture capital investor with more than 30 active investments in the portfolio in different funds. At Bynd Venture Capital we invest in companies: - At the seed / early stage - In IT/Digital and Sustainability (including Lifesciences, Clean Tech, among others) sectors - FromPortugal, Spain and any startup that has a direct connection with these markets (founders, tech team, investors, ...).
Show more...Investment focus
- Software, E-Commerce, Health Care
- Seed, Series A, Funding Round
- Portugal, Spain, United States
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Trebellar — Trebellar provides advanced data analytics for building occupancy, energy efficiency, and climate optimization. Maximize your workplace productivity with our intelligent building solutions.
- Guud Woman — Verbeter je cyclus met Guud Woman. Onze supplementen ondersteunen je hormonen en vruchtbaarheid, bevorderen een gezonde huid en meer.
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more...Investment focus
- Apps, Video, Medical
- Seed
- Portugal, United States
Portfolio highlights
- Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
- MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.
MSM is an early-stage generalist impact fund that invests all across Europe.
Show more...Investment focus
- Information Technology, Software, B2B
- Seed, Pre-Seed, Series A
- United Kingdom, Germany, Portugal
Portfolio highlights
- GoParity — GoParity is an online savings and investment platform that uses a P2P business model to simplify investment and allow citizens and companies to get a decent return on their sustainable loans. Citizens and companies invest their funds in projects they believe in to generate economic, social and environmental impact.We are driving the transitiontowards a more sustainable and inclusive economic system, making investment in sustainable solutions accessible to all, from citizens to small enterprises. Join us @ www.goparity.com
- Flecto — Flecto is the rental platform that makes businesses thrive in the circular economy. A flexible rental software for all types of businesses.
- WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
- Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
We support innovative tech ventures to unlock its potential by providing smart funding and hands-on advisory.
Show more...Investment focus
- VoIP, Software, Wireless
- Seed, Funding Round
- Portugal
Portfolio highlights
- Nonius Hospitality Technology — Integrated Cloud Based Hospitality Technology Solutions to Enhance Guest Experiences with Chromecast, TV, Wi-Fi, App, Signage and Voice.
- Magnomics — Overview: Magnomics is a diagnostics, medical technology company committed to delivering a new generation of rapid, portable molecular diagnostic tests with applications in the human health, veterinary, and food industry markets. Affordable, disposable diagnostic cartridges will be produced in large scale and shipped via global distributors. Theteam behind the company has world class experience in biotechnology, electronics and physics, with a proven track record in managing start-ups. Magnomics has a Letter of Intent from a leading dairy company and won the 2015 Kansas City Animal Health Investment Forum innovation award, as well as the Ag Biotech Entrepreneurial Showcase award in North Carolina in 2016. €1.6M in seed financing have been raised through grants and investments. Magnomics is seeking €1.5M to conclude the prototyping of its first product in the animal health space. Technology: Magnomics technology stands on four patent families, with more in the pipeline, and has been published over twenty times in prestigious scientific journals. Magnomics provides a portable and affordable PCR device that requires no training to operate. The product integrates sample preparation, amplification and DNA detection within a single cartridge using microfluidics, making use of a novel magnetoresistive DNA sensing technology. Market: The veterinary diagnostics market is hungry for innovation and has low regulatory barriers. This market is estimated at €4 billion, with an 8.6% expected growth for the period 2016 to 2021. Magnomics will focus on the detection of bovine mastitis - an inflammation of the dairy cow’s mammary gland, whose treatment depends on the bacteria involved. This ailment causes over €30 billion in annual losses for producers worldwide. In the initial target markets (North America, Europe and Brazil), there are 56 million dairy cows with an average mastitis base incidence 30%. Given a €25 price tag and some segmentation, this amounts to a serviceable market of close to €300M, in which a penetration of 10-15% is expectable. The product can be sold either directly to farmers or to veterinarians: strategic partnerships are being negotiated with large pharma/dairy players to ensure market access.Competition: Companies such as AAD, DeLaval, and PortaCheck already have on-site solutions, which include California Mastitis Tests (CMT), Somatic Cell Counters and variants (SCC), as well as lateral flow strips. These current on-site diagnostics tools indicate the presence of an infection but are unable to determine the pathogen, which is key to define an appropriate treatment. Culture testing (e.g. Idexx, Virbac) is the current benchmark and is being tried on site as well: although cheap, the added value is greatly diminished due to long waiting times and difficulties in setting up a working protocol. Finally, laboratories provide fast molecular solutions (e.g. ThermoFisher) that are fast but expensive, while requiring complicated logistics due to sample collection that increase lead times. Magnomics will bring these molecular solutions to the farm in a convenient and affordable product.
Boule develops, manufactures, and markets hematology analyzers for both human and veterinary markets. Read more about us here.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Series A
- Portugal
Portfolio highlights
- Biosurfit — At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Health Care, Medical Device, Medical
- Grant, Pre-Seed, Seed
- United Kingdom, Spain, Ireland
Portfolio highlights
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: